References
1. A.A. Deshpande et al., Pharm. Res.
14 (6), 815–819 (1997).
2. F. Stops et al., Int. J. Pharm.
308 (1–2), 8–13 (2006).
3. F. Stops et al., Int. J. Pharm.
308 (1–2), 14–24 (2006).
4. S.C. Sweetman, "Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Metronidazole," in The Complete Drug Reference, C.F. Rediguieri et al., Eds. (Pharmaceutical Press, London, 36th ed., 2009), pp. 837–841.
5. J.S. Simms-Cendan, J. Infect. Dis.
3 (5), 153–156 (1996).
6. J.W. Tracy and L.T. Webster, Jr., "Drugs Used in the Chemotherapy of Protozoal Infections," in The Pharmacological Basis of Therapeutics, J.G. Hardman, L.E. Limbird, and A.G. Gilman, Eds. (McGraw-Hill, New York, 10th ed., 2001), pp. 1105–1109.
7. K.C. Lamp et al., Clin. Pharmacokinet.
36 (5), 353–373 (1999).
8. E.D. Ralph et al., Antimicrob. Agents Chemother.
6 (6), 691–696 (1974).
9. B.N. Singh and K.H. Kim, J. Control Release
63 (3), 235–259 (2000).
10. S. Burton et al., J. Pharm. Pharmacol.
47 (11), 901–906 (1995).
11. V. Alvisi et al., Drugs Exp. Clin. Res.
22 (1), 29–33 (1996).
12. M. Rahman et al., J. Pharmaceutics Cosmetol.
1 (2), 81–92 (2011).
13. M.D. Chavanpatil et al., Int. J. Pharm.
316 (1–2), 86–92 (2006).
14. T. Higuchi, J. Pharm. Sci.
52 (12), 1145–1149 (1963).
15. S. Asnaashari et al., Pharm. Dev. Technol.
16 (4), 1–8 (2010).
|
